Immediate Impact
28 standout
Citing Papers
HER2-targeted therapies in cancer: a systematic review
2024 Standout
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
Works of Mateja Blas being referenced
HER2 in Gastric Cancer: An Immunohistochemical Study on Tissue Microarrays and the Coressponding Whole-Tissue Sections with a Supplemental Fish Study
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mateja Blas | 50 | 20 | 66 | 71 | 51 | 6 | 194 | |
| An Snyers | 13 | 62 | 11 | 24 | 156 | 9 | 182 | |
| Jonathan Naudé | 85 | 33 | 2 | 60 | 88 | 6 | 203 | |
| Jasper Yuen | 44 | 10 | 85 | 59 | 8 | 146 | ||
| F.W. Wheeler | 61 | 15 | 66 | 41 | 8 | 227 | ||
| Margaret C. Tod | 37 | 10 | 112 | 87 | 6 | 175 | ||
| Nina Boje Kibsgaard Jensen | 54 | 26 | 103 | 50 | 9 | 155 | ||
| Louis Deprez | 149 | 27 | 9 | 3 | 18 | 6 | 183 | |
| Dillon C. Chen | 7 | 18 | 133 | 6 | 49 | 6 | 226 | |
| Alexander Sachs | 25 | 3 | 60 | 6 | 26 | 5 | 129 | |
| Karen Nkiwane | 27 | 12 | 87 | 64 | 8 | 110 |
All Works
Login with ORCID to disown or claim papers
Loading papers...